06:41 AM EDT, 07/25/2024 (MT Newswires) -- AstraZeneca ( AZN ) reported Q2 earnings Thursday of $1.24 per diluted share, up from $1.17 a year earlier.

Three analysts surveyed by Capital IQ expected $1.36.

Revenue for the quarter ended June was $12.94 billion, compared with $11.42 billion a year earlier.

Analysts surveyed by Capital IQ expected $12.53 billion.

The company said it raised its full-year 2024 core EPS forecast to the mid-teens percentage from a low double-digit to low teens percentage previously. Analysts polled by Capital IQ expect normalized EPS of $8.26.

Total revenue is projected to grow in the mid-teens percentage, compared with the low double-digit to low-teens percentage previously expected. Analysts polled by Capital IQ expect $51.89 billion.

Price: 76.30, Change: -3.41, Percent Change: -4.28